The Pharma Data

DECEMBER 14, 2020

ICU nurse Sandra Lindsay, with Long Island Jewish Medical Center in Queens, New York, received the Pfizer-BioNTech COVID-19 vaccine. Food and Drug Administration (FDA) ’ s Vaccines and Related Biological Products Advisory Committee on Thursday, December 17. billion worth of vaccines. This would be a very good thing.

Vaccination 52

Vaccination Vaccine Allergies Genome 52

The Pharma Data

JANUARY 24, 2021

Gritstone Oncology , based in Emeryville, California, announced that it is advancing development of its own second-generation vaccine against COVID-19. It inked a deal with the National Institute of Allergy and Infectious Diseases (NIAID) to launch a Phase I trial. COVID-19-Related. BT-001 is based on the patented Invir.IO

Trials 52

Trials Allergies In-Vitro Antibody 52

The Pharma Data

DECEMBER 22, 2020

Seeking to reassure a troubled nation, President-Elect Joe Biden received the first dose of the two-dose Pfizer COVID-19 vaccine on Monday. Biden said, “I’m doing this to demonstrate that people should be prepared when it’s available to take the vaccine,” the New York Times reported. is at the moment not known.

Packaging 52

Packaging Packaging Vaccination Vaccine 52

The Pharma Data

DECEMBER 23, 2020

and the Trump Administration were close to a deal on Tuesday that would get more of the company’s coronavirus vaccine to Americans in the coming year. So far, only two pharmaceutical companies — Pfizer and Moderna — have won emergency approval for their COVID-19 vaccines. WEDNESDAY, Dec.

Vaccination 52

Vaccination Vaccine Allergies Nurses 52

The Pharma Data

JANUARY 13, 2021

Health Secretary Alex Azar said Tuesday that the federal government would now release all available vaccine doses and told states to vaccinate every American aged 65 and older. “Every vaccine dose that is sitting in a warehouse rather than going into an arm could mean one more life lost or one more hospital bed occupied.”

Vaccination 52

Vaccination Vaccine Scientist Production 52